Top 400 Asset Managers: Outcomes revolution in investment management and pharmaceuticals

By Mitesh Sheth June 2013 (Magazine)

Mitesh Sheth outlines what investment managers can learn from the transformation taking place in the pharmaceutical industry

This content is only available to IPE Members

Already an IPE Member? Sign in here

Unlock your IPE Membership Package

For unlimited access to IPE’s industry-leading market intelligence, comprising news, data and long-form content on European pensions and institutional investment.

What type of organisation do you work for?
Asset Owner
Asset Manager
Real Assets
Consultancy
Professional Services

Join now

  • Secure online payment
  • Free European delivery
  • Best value for price

IPE Membership

IPE has created a suite of products and services for Europe’s institutional investment and pensions community.

Premium content
Pension fund interviews,
country analysis and data
Opinion and analysis
Asset classes
and strategies in depth
 
access-denied-testimonial

IPE covers a good variety of very current and relevant topics. It is good to read the high-level, independent and objective perspectives from pension funds in other European countries; many of them are dealing with the same issues as we are, so it is interesting to learn from their experiences, especially when they are ahead of where we are on the curve.

Markus Schaen , Senior Fund Manager, MN,
The Netherlands
SEE HOW IPE CAN HELP YOUR BUSINESS